Correlation Between FrontView REIT, and OliX PharmaceuticalsI
Can any of the company-specific risk be diversified away by investing in both FrontView REIT, and OliX PharmaceuticalsI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FrontView REIT, and OliX PharmaceuticalsI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FrontView REIT, and OliX PharmaceuticalsInc, you can compare the effects of market volatilities on FrontView REIT, and OliX PharmaceuticalsI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FrontView REIT, with a short position of OliX PharmaceuticalsI. Check out your portfolio center. Please also check ongoing floating volatility patterns of FrontView REIT, and OliX PharmaceuticalsI.
Diversification Opportunities for FrontView REIT, and OliX PharmaceuticalsI
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between FrontView and OliX is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding FrontView REIT, and OliX PharmaceuticalsInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OliX PharmaceuticalsInc and FrontView REIT, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FrontView REIT, are associated (or correlated) with OliX PharmaceuticalsI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OliX PharmaceuticalsInc has no effect on the direction of FrontView REIT, i.e., FrontView REIT, and OliX PharmaceuticalsI go up and down completely randomly.
Pair Corralation between FrontView REIT, and OliX PharmaceuticalsI
Considering the 90-day investment horizon FrontView REIT, is expected to under-perform the OliX PharmaceuticalsI. But the stock apears to be less risky and, when comparing its historical volatility, FrontView REIT, is 3.29 times less risky than OliX PharmaceuticalsI. The stock trades about -0.03 of its potential returns per unit of risk. The OliX PharmaceuticalsInc is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 2,130,000 in OliX PharmaceuticalsInc on September 20, 2024 and sell it today you would lose (168,000) from holding OliX PharmaceuticalsInc or give up 7.89% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 11.62% |
Values | Daily Returns |
FrontView REIT, vs. OliX PharmaceuticalsInc
Performance |
Timeline |
FrontView REIT, |
OliX PharmaceuticalsInc |
FrontView REIT, and OliX PharmaceuticalsI Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with FrontView REIT, and OliX PharmaceuticalsI
The main advantage of trading using opposite FrontView REIT, and OliX PharmaceuticalsI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FrontView REIT, position performs unexpectedly, OliX PharmaceuticalsI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OliX PharmaceuticalsI will offset losses from the drop in OliX PharmaceuticalsI's long position.FrontView REIT, vs. GameStop Corp | FrontView REIT, vs. Analog Devices | FrontView REIT, vs. Boston Omaha Corp | FrontView REIT, vs. Fluent Inc |
OliX PharmaceuticalsI vs. Samsung Biologics Co | OliX PharmaceuticalsI vs. SK Bioscience Co | OliX PharmaceuticalsI vs. Green Cross Lab | OliX PharmaceuticalsI vs. MedPacto |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
CEOs Directory Screen CEOs from public companies around the world |